Article Abstract

Adjuvant TKIs: still an optimal choice

Authors: Si-Yang Liu, Yi-Long Wu

Abstract

Thanks for Pro. Hai-Quan Chen and colleagues for their interest in our study and appreciate it raises questions about the trial design and eventual OS benefits for EGFR mutant patients received adjuvant TKI therapy (1).

Article Options

Download Citation